DaBomb Protein Biotech Corp. (TPEX:6578)
15.75
+0.05 (0.32%)
Apr 29, 2026, 1:30 PM CST
DaBomb Protein Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,129 | 1,374 | 1,334 | 1,251 | 636 | 577 | Upgrade
|
| Market Cap Growth | -10.11% | 3.00% | 6.64% | 96.64% | 10.20% | -9.84% | Upgrade
|
| Enterprise Value | 1,072 | 1,303 | 1,309 | 1,326 | 901 | 687 | Upgrade
|
| Last Close Price | 15.70 | 19.10 | 19.40 | 20.10 | 14.87 | 16.11 | Upgrade
|
| PE Ratio | - | - | 114.64 | - | - | - | Upgrade
|
| PS Ratio | 3.65 | 4.44 | 3.95 | 3.25 | 1.47 | 1.23 | Upgrade
|
| PB Ratio | 1.14 | 1.39 | 1.23 | 1.31 | 0.88 | 0.86 | Upgrade
|
| P/TBV Ratio | 1.14 | 1.39 | 1.23 | 1.31 | 0.88 | 0.86 | Upgrade
|
| P/FCF Ratio | - | - | 77.04 | - | - | - | Upgrade
|
| P/OCF Ratio | 67.85 | 82.55 | 28.05 | 192.27 | 32.28 | - | Upgrade
|
| EV/Sales Ratio | 3.46 | 4.21 | 3.87 | 3.45 | 2.08 | 1.46 | Upgrade
|
| EV/EBITDA Ratio | 83.62 | 124.09 | 125.30 | - | - | - | Upgrade
|
| EV/FCF Ratio | -50.92 | - | 75.57 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.15 | 0.44 | 0.68 | 0.92 | Upgrade
|
| Debt / EBITDA Ratio | 5.79 | 5.79 | 14.22 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 9.71 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.06 | -0.08 | 0.04 | 0.41 | 0.62 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.52 | -5.52 | -8.18 | -3.76 | -8.02 | -10.57 | Upgrade
|
| Net Debt / FCF Ratio | 2.75 | 2.75 | -4.93 | -3.03 | -1050.38 | -1.12 | Upgrade
|
| Asset Turnover | 0.26 | 0.26 | 0.25 | 0.29 | 0.33 | 0.39 | Upgrade
|
| Inventory Turnover | 9.05 | 9.05 | 9.91 | 9.26 | 9.16 | 9.62 | Upgrade
|
| Quick Ratio | 2.06 | 2.06 | 1.61 | 1.21 | 1.07 | 1.14 | Upgrade
|
| Current Ratio | 2.67 | 2.67 | 3.66 | 2.18 | 1.57 | 1.81 | Upgrade
|
| Return on Equity (ROE) | -6.67% | -6.67% | 1.14% | -6.77% | -6.37% | -9.09% | Upgrade
|
| Return on Assets (ROA) | -1.46% | -1.46% | -0.08% | -1.40% | -2.98% | -3.33% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.99% | -2.91% | -0.13% | -2.96% | -5.89% | -7.00% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.80% | -2.80% | -0.20% | -2.90% | -5.90% | -5.70% | Upgrade
|
| Earnings Yield | -6.14% | -5.05% | 0.87% | -4.56% | -7.02% | -10.82% | Upgrade
|
| FCF Yield | -1.86% | -1.53% | 1.30% | -0.99% | -0.04% | -65.19% | Upgrade
|
| Dividend Yield | 2.55% | - | 0.88% | 2.74% | 6.73% | - | Upgrade
|
| Payout Ratio | - | - | 296.89% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.11% | -0.11% | -34.30% | -38.27% | -19.16% | 0.13% | Upgrade
|
| Total Shareholder Return | 2.32% | -0.11% | -33.43% | -35.53% | -12.43% | 0.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.